Patel Mehulkumar Kiritbhai

1) Apollo Hospitals witnessed smart rally although Sensex nosedived over 1000 points. Good quarterly results and traders focus on the defensive stock in the volatile market lifted Apollo Hospital.2) Maruti Suzuki Subscribe allows a customer to use a new car without actually owning it and by paying an all-inclusive monthly fee that comprehensively covers complete maintenance, insurance and roadside assistance," it said. Customers can select subscription duration ranging from 12 months to 48 months and pay a monthly subscription charge starting Rs 14,463 (including taxes) for Swift Lxi in Delhi for a tenure of 48 months. After the completion of subscription tenure, the customer can also opt to upgrade the vehicle, extend, or buy the car at market price. Last month the project was launched as a pilot in Hyderabad & Pune. #MOMarketUpdates #MotilalOswal #Indianstockmarket #BSE #NSE #MarutiSuzuki #ApolloHospitals #Sensex #Nifty

1) ICRA assigns stable outlook to bank facilities and NCDs of Jindal Steel. The stock jumped 4%.2) Hexaware says that the promoter HT Global Holdings has accepted the discovered price of Rs 475 per share, as the final price for the delisting offer. The promoter will acquire 8.72 crore shares, post the acquisition, promoter shareholding in the company will be 91.16%. #MOMarkrtUpdates #MotilalOswal #indianstockmarket #nifty #sensex #jindalsteel #hexaware

As the world highly depends on technology during Covid-19, the technology stocks the IT stocks are gaining attention. HCL has hit a 52-week new high. #MOMarketUpdates #MotilalOswal #ITstocks #indianstockmarket #stockrecommendation #HCL #TCS

HAAH Automotive Holdings Inc., a US automobile distributor, has offered to invest 300 billion won ($258 million) in Ssangyong Motor Co. as part of its bid to take a significant stake in the South Korean automaker, according to sources in the investment banking industry. Expect positive for M&M. #MOMarketUpdates #MotilalOswal #IndianStockMarket #NSE #BSE #Mahindra

The Pharma stocks are positive due to multiple approvals of US FDA for different medicines. The companies are also manufacturing the drugs for the primary treatment of Covid-19. Dr Reddy's Laboratories reclaimed the tag of being the second most valuable listed pharmaceutical company. Sun Pharma is the most valued listed company of India with the market cap of Rs 1.26lakh cr. With a favourable ruling in the appeals court, the odds of launching gVascepa also rise considerably. Bristol Myers Squibb had inked a patent settlement with Dr. Reddy’s Laboratories, allowing the Indian generics company to start with a “volume-limited” launch sometime after March 2022. The exact date of the rollout, and amount of generic Revlimid Dr. Reddy’s will be allowed to sell, are confidential. But on January 31, 2026, the company will have a license to sell its generic Revlimid with no limits. #MOMarketUpdates #IndianStockMarket #MotilalOswal #NiftyPharma #NSE #BSE #Recommendation #Stocktip #Stockrecommendation

1) Happiest Minds Technologies Ltd. debuted on the bourses at a 115% premium to its issue price AT Rs166 a share, a week after concluding its initial public offering on a remarkable note. The Rs 702-crore maiden offer was subscribed 151 times. It has gained 125% to close at Rs371 against its IPO price amid 52cr shares traded on NSE.2) Domestic Pharma major Dr Reddy closed at an all-time high of Rs4827 after the news that the Russia-based Russian Direct Investment Fund (RDIF) to distribute 10cr Covid-19 vaccine doses in India. Moreover, the Company launched Eye Allergy drop in US Market.3) SBI - The country’s largest lender State Bank of India could be sitting on a goldmine when it comes to its digital start up YONO (You only need one). The super-app could be valued at $40 billion with the lender considering long term plans to hive it off as a separate entity once it assumes a specific size- says SBI Chairman. #MOMarketUpdates #MotilalOswal #IndianStockMarket #NSE #BSE #Nifty #sensex #IPO #Pharma #SBIYONO

Russia’s RDIF to sell 100m doses of Covid-19 vaccine to India. Russian sovereign wealth fund to cooperate with India’s Dr. Reddy’s Laboratories on clinical trials and distribution of Sputnik V vaccine against coronavirus, Russian Direct Investment Fund says in a statement. RDIF to also sell as many as 50m doses to Brazil, 32m to Mexico. #MOMarketUpdates #MotilalOswal #DrReddys #Indianstockmarket #marketrecommendation #NSE #BSE #nifty #sensex

1) RBI has exempted ICICI Bank, from the Banking Regulation Act, 1949 with respect to shareholding above 30% in ICICI Lombard General Insurance and ICICI Prudential Life Insurance, for a period of three years Sept. 2023. The exemption during its operation may permit both ICICI Lombard General Insurance and/or ICICI Prudential Life to consider strategic options such as mergers and acquisitions or capital raise which have the potential of reducing the Bank’s shareholding. There would be no impact on the current distribution arrangements. This exemption will facilitate compliance with rules if there is a proposed acquisition of another general insurance business made by ICICI Lombard General Insurance. If any merger or acquisition proposal gets consummated, it will result in ICICI Bank’s shareholding in ICICI Lombard General Insurance reducing to less than 50%.2) The retail players are favourable due to the foreign equity funds investment in Indian Retail sectors.3) Ugar Sugar, Andhra Sugar, Bajaj Hindustan, Balrampur Chini, Dhampur Sugar are witnessing fresh buying after the news that the government is likely to allow sugar mills to export their Maximum Admissible Export Quantity for 2019-20 (Oct-Sep) till the end of this year, a senior government official said today. The companies will get 180 days to claim the subsidy instead of 90 days. #MOMarketUpdates #MotilalOswal #ICICIBank #SugarStocks #RetailStores #indianstockmarket #nifty #BSE #NSE

HCL Tech Sees 2Q Rev Growth Over 3.5% Q/q in Constant Currency. Revenue growth to be a result of "broad-based momentum across all service lines, verticals and geographies," HCL Technologies Ltd. says in a statement to exchanges. Company Says EBIT margin for the current quarter is expected to be between 20.5% and 21%. "Good Booking momentum continues this quarter, led by Life Sciences & Healthcare, Telecom & Media and Financial Services verticals," HCL Tech says. "The pipeline continues to look healthy across service lines, verticals and geographies," according to the statement.TCS became the second Indian firm to attain a market valuation of over Rs 9 lakh crore after Reliance Industries. The NiftyIT Index gained today more than 4% as companies present strong quarterly results & projections. #MOMarketUpdates #MotilalOswal #NiftyIT #Indianstockmarket #Itcompanies #HCL #TCS #NSE #BSE #Infosys